Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.17 Insider Own4.87% Shs Outstand181.25M Perf Week-6.60%
Market Cap340.20M Forward P/E- EPS next Y-0.07 Insider Trans-3.57% Shs Float175.89M Perf Month8.24%
Income-31.56M PEG- EPS next Q-0.04 Inst Own74.67% Short Float3.42% Perf Quarter-16.74%
Sales163.76M P/S2.08 EPS this Y32.38% Inst Trans-0.34% Short Ratio3.85 Perf Half Y11.52%
Book/sh0.27 P/B6.89 EPS next Y50.70% ROA-15.84% Short Interest6.01M Perf Year-9.36%
Cash/sh0.39 P/C4.71 EPS next 5Y- ROE-58.44% 52W Range1.21 - 3.08 Perf YTD-14.81%
Dividend Est.- P/FCF- EPS past 5Y13.81% ROI-24.72% 52W High-40.26% Beta1.26
Dividend TTM- Quick Ratio1.72 Sales past 5Y16.80% Gross Margin54.80% 52W Low52.70% ATR (14)0.13
Dividend Ex-Date- Current Ratio2.41 EPS Y/Y TTM32.90% Oper. Margin-29.38% RSI (14)48.90 Volatility5.09% 7.78%
Employees288 Debt/Eq2.04 Sales Y/Y TTM5.26% Profit Margin-19.27% Recom1.67 Target Price4.40
Option/ShortYes / Yes LT Debt/Eq1.59 EPS Q/Q39.27% Payout- Rel Volume0.26 Prev Close1.85
Sales Surprise0.39% EPS Surprise-4.38% Sales Q/Q23.86% EarningsMay 02 AMC Avg Volume1.56M Price1.84
SMA20-0.46% SMA501.18% SMA2001.66% Trades Volume407,926 Change-0.54%
Date Action Analyst Rating Change Price Target Change
Apr-12-24Initiated Craig Hallum Buy $5
Jan-20-23Downgrade BTIG Research Buy → Neutral
Jan-17-23Downgrade Stephens Overweight → Equal-Weight $3.75
Oct-08-20Resumed BTIG Research Buy $9
Jun-16-20Resumed Cantor Fitzgerald Overweight $9
Feb-26-20Initiated BTIG Research Buy $7
Nov-13-19Upgrade BTIG Research Neutral → Buy $7
Aug-28-19Initiated Stifel Buy
Aug-23-19Resumed Stephens Overweight
Jan-05-18Resumed Cantor Fitzgerald Overweight
May-22-24 08:30AM
May-03-24 10:40AM
May-02-24 08:59PM
06:04PM Loading…
Apr-18-24 08:30AM
Mar-26-24 08:30AM
Mar-19-24 08:00AM
Mar-15-24 01:49AM
Mar-07-24 01:40PM
06:23AM Loading…
Mar-06-24 06:23AM
Mar-05-24 09:53PM
Feb-23-24 11:56AM
Feb-20-24 08:30AM
Feb-01-24 08:30AM
Jan-15-24 09:30AM
Jan-08-24 08:30AM
Nov-03-23 09:19AM
Nov-02-23 06:43PM
08:30AM Loading…
Oct-19-23 08:30AM
Oct-10-23 08:30AM
Sep-27-23 08:30AM
Sep-12-23 08:30AM
Aug-02-23 05:15PM
Jul-31-23 12:36PM
Jul-19-23 08:30AM
Jul-03-23 05:13PM
Jun-15-23 08:30AM
Jun-14-23 08:30AM
Jun-07-23 10:30AM
Jun-05-23 08:30AM
May-30-23 07:16AM
May-04-23 05:15PM
May-02-23 12:25PM
Apr-20-23 08:30AM
Apr-18-23 10:54AM
Mar-10-23 09:24AM
Mar-09-23 11:45AM
Feb-28-23 04:00PM
Feb-21-23 11:00AM
Feb-15-23 08:30AM
Feb-10-23 08:30AM
Jan-19-23 11:45AM
Jan-09-23 08:30AM
Dec-21-22 05:50AM
Nov-09-22 05:58AM
Nov-04-22 08:00AM
Nov-03-22 05:55PM
Nov-02-22 01:52PM
Nov-01-22 08:00AM
Oct-20-22 08:30AM
Sep-26-22 08:00AM
Sep-21-22 09:35AM
Sep-14-22 11:55AM
Sep-13-22 11:17AM
Aug-29-22 09:35AM
Aug-24-22 07:58AM
Aug-12-22 08:00AM
Aug-05-22 01:00PM
Aug-04-22 05:25PM
Jul-28-22 09:48AM
Jul-21-22 08:00AM
Jul-14-22 12:00PM
Jul-13-22 11:37AM
Jul-05-22 05:00PM
Jun-23-22 09:55AM
Jun-14-22 08:00AM
Jun-03-22 09:55AM
May-17-22 05:00AM
May-16-22 09:55AM
May-15-22 08:42AM
May-06-22 02:30AM
May-05-22 05:15PM
May-03-22 08:00AM
Apr-28-22 08:35AM
Apr-25-22 08:00AM
Apr-21-22 08:00AM
Apr-07-22 11:39AM
Feb-25-22 08:00AM
Feb-23-22 10:00AM
Feb-22-22 10:00PM
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shan HuaDirectorMay 13 '24Buy1.992,5004,97532,386May 14 06:30 PM
NACHTSHEIM JAMI KDirectorMay 10 '24Buy1.792,0003,578108,362May 13 05:09 PM
Witney FrankDirectorMay 09 '24Buy1.8920,00037,800180,059May 10 08:17 PM
Swisher Daniel N JRDirectorMay 09 '24Buy1.882,5004,689107,045May 09 05:15 PM
Greenman William MarinerPresident and CEOMar 14 '24Sale2.0263,611128,1953,181,281Mar 14 09:30 PM
Jayaraman Vivek KChief Operating OfficerMar 14 '24Sale1.9726,79452,902878,653Mar 14 09:33 PM
Green Kevin DennisChief Financial OfficerMar 14 '24Sale1.9721,49742,444618,750Mar 14 09:53 PM
Jensen ChrystalChief Legal OfficerMar 14 '24Sale1.9717,82435,192490,912Mar 14 09:47 PM
Benjamin Richard JChief Medical OfficerMar 14 '24Sale1.9717,73835,022459,612Mar 14 09:15 PM
CORASH LAURENCE MChief Scientific OfficerMar 14 '24Sale1.9714,36028,3522,339,740Mar 14 09:22 PM
Greenman William MarinerPresident and CEOMar 13 '24Sale2.0662,315128,1823,244,892Mar 14 09:30 PM
Jayaraman Vivek KChief Operating OfficerMar 13 '24Sale2.0626,24753,990905,447Mar 14 09:33 PM
Green Kevin DennisChief Financial OfficerMar 13 '24Sale2.0221,05842,438640,247Mar 14 09:53 PM
Moore CarolSVP Reg. & QualityMar 13 '24Sale2.0220,61941,553490,623Mar 14 09:49 PM
Jensen ChrystalChief Legal OfficerMar 13 '24Sale2.0617,46035,915508,736Mar 14 09:47 PM
Benjamin Richard JChief Medical OfficerMar 13 '24Sale2.0617,37735,744477,350Mar 14 09:15 PM
CORASH LAURENCE MChief Scientific OfficerMar 13 '24Sale2.0614,06728,9362,354,100Mar 14 09:22 PM
Benjamin Richard JChief Medical OfficerMar 08 '24Sale2.4029,37870,457478,061Mar 12 06:10 PM
BJERKHOLT ERICDirectorDec 13 '23Buy1.6210,00016,200142,133Dec 13 05:55 PM
Lucena AnnDirectorAug 22 '23Buy1.697,50012,63872,284Aug 23 06:11 PM
BJERKHOLT ERICDirectorAug 21 '23Buy1.7210,00017,151132,133Aug 23 06:08 PM
Swisher Daniel N JRDirectorMay 26 '23Buy1.915,0009,535118,808May 30 03:45 PM